Back to Search Start Over

Cheilitis granulomatosa and Melkersson?Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patients

Authors :
N Sepp
H Tilg
Gudrun Ratzinger
W Vogetseder
Source :
Journal of the European Academy of Dermatology and Venereology. 21:1065-1070
Publication Year :
2007
Publisher :
Wiley, 2007.

Abstract

Background Cheilitis granulomatosa and Melkersson–Rosenthal syndrome are both rare and benign diseases. Because of their granulomatous character, a relationship to Crohn's disease has been suggested. Furthermore, because of their unknown aetiology, treatment is difficult, and evaluation of response is hampered by the natural tendency to spontaneous resolution and recurrence. Objectives and methods To evaluate gastrointestinal involvement by clinical history, conventional endoscopy, and capsule endoscopy as well as to compare efficacy of treatment modalities on a series of 14 patients, one of the biggest collectives reported. Results Four patients (4 of 14) were previously, simultaneously, or subsequently diagnosed with Crohn's disease. In six patients (6 of 14) with minor gastrointestinal symptoms as flatulence, occasional constipation, diarrhoea, or admixture of mucus with the stool, we could not detect any signs of inflammatory bowel disease by capsule endoscopy. Nine patients received clofazimine, and eight patients responded to treatment (four complete responses, four partial responses). Two patients were successfully treated with infliximab. Systemic methylprednisone was not successful in two patients. Conclusion Close to 30% of patients showed an association of cheilitis granulomatosa and Crohn's disease. Forty-three per cent of patients reported minor gastrointestinal irregularities without any detectable changes of Crohn's disease. Clofazimine seems to be an effective treatment, although long-term application is necessary with frequent aggravation in the beginning. Infliximab, an effective drug in Crohn's disease, could be a promising treatment option for severe cases.

Details

ISSN :
14683083 and 09269959
Volume :
21
Database :
OpenAIRE
Journal :
Journal of the European Academy of Dermatology and Venereology
Accession number :
edsair.doi.dedup.....e49a19dab5591d72bd39ebb031c97321
Full Text :
https://doi.org/10.1111/j.1468-3083.2007.02194.x